Kao Raymond, Xenocostas Anargyros, Rui Tao, Yu Pei, Huang Weixiong, Rose James, Martin Claudio M
Department of National Defense, Canadian Forces Medical Group, 1745 Alta Vista Drive, Ottawa, Ontario, K1A 0K6, Canada.
Crit Care. 2007;11(3):R58. doi: 10.1186/cc5920.
The relationship between oxygen delivery and consumption in sepsis is impaired, suggesting a microcirculatory perfusion defect. Recombinant human erythropoietin (rHuEPO) regulates erythropoiesis and also exerts complex actions promoting the maintenance of homeostasis of the organism under stress. The objective of this study was to test the hypothesis that rHuEPO could improve skeletal muscle capillary perfusion and tissue oxygenation in sepsis.
Septic mice in three experiments received rHu-EPO 400 U/kg subcutaneously 18 hours after cecal ligation and perforation (CLP). The first experiment measured the acute effects of rHuEPO on hemodynamics, blood counts, and arterial lactate level. The next two sets of experiments used intravital microscopy to observe capillary perfusion and nicotinamide adenine dinucleotide (NADH) fluorescence post-CLP after treatment with rHuEPO every 10 minutes for 40 minutes and at 6 hours. Perfused capillary density during a three-minute observation period and NADH fluorescence were measured.
rHuEPO did not have any effects on blood pressure, lactate level, or blood cell numbers. CLP mice demonstrated a 22% decrease in perfused capillary density compared to the sham group (28.5 versus 36.6 capillaries per millimeter; p < 0.001). Treatment of CLP mice with rHuEPO resulted in an immediate and significant increase in perfused capillaries in the CLP group at all time points compared to baseline from 28.5 to 33.6 capillaries per millimeter at 40 minutes; p < 0.001. A significant increase in baseline NADH, suggesting tissue hypoxia, was noted in the CLP mice compared to the sham group (48.3 versus 43.9 fluorescence units [FU]; p = 0.03) and improved with rHuEPO from 48.3 to 44.4 FU at 40 minutes (p = 0.02). Six hours after treatment with rHuEPO, CLP mice demonstrated a higher mean perfused capillary density (39.4 versus 31.7 capillaries per millimeter; p < 0.001) and a lower mean NADH fluorescence as compared to CLP+normal saline mice (49.4 versus 52.7 FU; p = 0.03).
rHuEPO produced an immediate increase in capillary perfusion and decrease in NADH fluorescence in skeletal muscle. Thus, it appears that rHuEPO improves tissue bioenergetics, which is sustained for at least six hours in this murine sepsis model.
脓毒症中氧输送与氧消耗之间的关系受损,提示存在微循环灌注缺陷。重组人促红细胞生成素(rHuEPO)可调节红细胞生成,还能在应激状态下发挥复杂作用,促进维持机体的内环境稳定。本研究的目的是验证rHuEPO可改善脓毒症小鼠骨骼肌毛细血管灌注和组织氧合这一假说。
在三项实验中,脓毒症小鼠在盲肠结扎穿孔(CLP)术后18小时皮下注射400 U/kg的rHu - EPO。第一项实验测量rHuEPO对血流动力学、血细胞计数和动脉血乳酸水平的急性影响。接下来的两组实验采用活体显微镜观察CLP术后经rHuEPO治疗的小鼠,每10分钟观察一次,共观察40分钟,并在6小时时观察毛细血管灌注和烟酰胺腺嘌呤二核苷酸(NADH)荧光情况。测量三分钟观察期内的灌注毛细血管密度和NADH荧光。
rHuEPO对血压、乳酸水平或血细胞数量无任何影响。与假手术组相比,CLP小鼠的灌注毛细血管密度降低了22%(每毫米分别为28.5根和36.6根毛细血管;p < 0.001)。与基线相比,用rHuEPO治疗CLP小鼠后,在所有时间点CLP组的灌注毛细血管均立即显著增加,从每毫米28.5根增加到40分钟时的33.6根;p < 0.001。与假手术组相比,CLP小鼠的基线NADH显著升高,提示组织缺氧(分别为48.3和43.9荧光单位[FU];p = 0.03),经rHuEPO治疗后,40分钟时从48.3降至44.4 FU(p = 0.02)。rHuEPO治疗6小时后,与CLP +生理盐水组小鼠相比,CLP小鼠的平均灌注毛细血管密度更高(每毫米分别为39.4根和31.7根毛细血管;p < 0.001),平均NADH荧光更低(分别为49.4和52.7 FU;p = 0.03)。
rHuEPO可使骨骼肌毛细血管灌注立即增加,NADH荧光降低。因此,在该小鼠脓毒症模型中,rHuEPO似乎可改善组织生物能量代谢,且这种改善至少可持续6小时。